J.R. Woodburn - Concepedia

Author

J.R. Woodburn

Also Known As

J R Woodburn, J. R. WOODBURN, J. R. Woodburn, J. WOODBURN, J.R Woodburn, J.R. Woodburn, James R Woodburn, James R. Woodburn

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)

About

J.R. Woodburn is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	882
2	Health Sciences	1	1	66
3	Natural Sciences	1	1	28
4	Public Health	1	1	114
5	Biochemistry	1	1	28

J.R. Woodburn

Publications

Citations

H-Index

Page 1

	Year	Citations
Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer Andrew Barker, Keith H. Gibson, Walter Grundy, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDrug TargetingOncologyMedicineReceptor Tyrosine Kinase	2001	559
ICI 176,334: A NOVEL NON–STEROIDAL, PERIPHERALLY SELECTIVE ANTIANDROGEN B. Valcaccia, J.R. Woodburn, Howard Tucker Journal of Endocrinology	1987	129
EFFECT OF SOME TRIPHENYLETHYLENES ON OESTRADIOL BINDING IN VITRO TO MACROMOLECULES FROM UTERUS AND ANTERIOR PITUITARY Joanne C Skidmore, A. L. WALPOLE, J.R. Woodburn Journal of Endocrinology Endocrine DisruptorsFertilityEndocrine MechanismMedicineClomiphene Isomers	1972	114
ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT J.R. Woodburn, Andrew Barker, Keith H. Gibson, Journal of Immunotherapy Novel TherapyMedicineTheatreReceptor Tyrosine KinaseA. J.	1997	66
Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines Keith H. Gibson, Walter Grundy, Andrew A. Godfrey, Bioorganic & Medicinal Chemistry Letters Signaling PathwayMedicineReceptor Tyrosine KinaseCancer GrowthNovel Quinazolines	1997	55
Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells Tom C. Freeman, Brenda J Curry, J Calam, Gastroenterology Signal TransductionPancreatic CancerPathologyMedicineCell Biology	1990	33
Conformationally restrained cyclic peptides as antaconists of luteinizing hormone-releasing hormone Anand S. Dutta, James J. Gormley, Peter F. McLachlan, Biochemical and Biophysical Research Communications Chemical BiologySignal TransductionBiochemistryMedicineNatural Sciences	1989	28
EGF receptor tyrosine kinase inhibitors as anti-cancer agents - pre-clinical and early clinical profile of ZD 1839 J.R. Woodburn, Charles Morris, Hanna Kelly, Cellular & Molecular Biology Letters Anti-cancer AgentsOncologyMedicinePathologyZd 1839	1998	14
New targets for therapeutic attack A. E. Wakeling, Andrew Barker, D H Davies, Endocrine Related Cancer New TargetsDrug TargetDrug TargetingMedicineImmunology	1997	13

Page 1